240 related articles for article (PubMed ID: 30923991)
1. Pharmacological management of cardiac cachexia: a review of potential therapy options.
Rolfe M; Kamel A; Ahmed MM; Kramer J
Heart Fail Rev; 2019 Sep; 24(5):617-623. PubMed ID: 30923991
[TBL] [Abstract][Full Text] [Related]
2. Cardiac cachexia: a systematic overview.
von Haehling S; Lainscak M; Springer J; Anker SD
Pharmacol Ther; 2009 Mar; 121(3):227-52. PubMed ID: 19061914
[TBL] [Abstract][Full Text] [Related]
3. [Heart failure and cachexia].
Tabet JY; Meurin P; Ben Driss A; Logeart D; Héliès-Toussaint C; Tartière JM; Cohen-Solal A; Grynberg A; Bourdel-Marchasson I
Arch Mal Coeur Vaiss; 2006 Dec; 99(12):1203-9. PubMed ID: 18942522
[TBL] [Abstract][Full Text] [Related]
4. Nutrition and heart failure: impact of drug therapies and management strategies.
Dunn SP; Bleske B; Dorsch M; Macaulay T; Van Tassell B; Vardeny O
Nutr Clin Pract; 2009; 24(1):60-75. PubMed ID: 19244150
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
6. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
Adigun AQ; Ajayi AA
Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
[TBL] [Abstract][Full Text] [Related]
7. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
van Diepen S; Reynolds HR; Stebbins A; Lopes RD; Džavík V; Ruzyllo W; Geppert A; Widimsky P; Ohman EM; Parrillo JE; Dauerman HL; Baran DA; Hochman JS; Alexander JH
Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin-aldosterone system and heart failure.
Sayer G; Bhat G
Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic management of heart failure: neurohormonal agents.
Moser DK
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and immunologic derangements in cardiac cachexia: where to from here?
Strassburg S; Anker SD
Heart Fail Rev; 2006 Mar; 11(1):57-64. PubMed ID: 16819578
[TBL] [Abstract][Full Text] [Related]
11. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.
Beusekamp JC; Tromp J; van der Wal HH; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Rossignol P; Zannad F; Voors AA; van der Meer P
Eur J Heart Fail; 2018 May; 20(5):923-930. PubMed ID: 29327797
[TBL] [Abstract][Full Text] [Related]
12. Update on recent clinical trials in congestive heart failure.
Betkowski AS; Hauptman PJ
Curr Opin Cardiol; 2000 Jul; 15(4):293-303. PubMed ID: 11139094
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
14. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
Cohn JN
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
[TBL] [Abstract][Full Text] [Related]
15. Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts.
Mehra MR; Uber PA; Potluri S
Am J Med Sci; 2002 Nov; 324(5):267-75. PubMed ID: 12449448
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological treatment of cachexia.
Argilés JM; Almendro V; Busquets S; López-Soriano FJ
Curr Drug Targets; 2004 Apr; 5(3):265-77. PubMed ID: 15058312
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
Miller AB; Srivastava P
Cardiol Clin; 2001 May; 19(2):195-202, v. PubMed ID: 11407105
[TBL] [Abstract][Full Text] [Related]
18. Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.
von Haehling S; Stepney R; Anker SD
Int J Cardiol; 2010 Oct; 144(3):347-9. PubMed ID: 20561693
[TBL] [Abstract][Full Text] [Related]
19. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Springer J; Tschirner A; Haghikia A; von Haehling S; Lal H; Grzesiak A; Kaschina E; Palus S; Pötsch M; von Websky K; Hocher B; Latouche C; Jaisser F; Morawietz L; Coats AJ; Beadle J; Argiles JM; Thum T; Földes G; Doehner W; Hilfiker-Kleiner D; Force T; Anker SD
Eur Heart J; 2014 Apr; 35(14):932-41. PubMed ID: 23990596
[TBL] [Abstract][Full Text] [Related]
20. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
